QCM
IMVT icon

Quantinno Capital Management’s Immunovant IMVT Stock Holding History

Quantinno Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$994K Buy
40,030
+25,787
+181% +$668K ﹤0.01% 2169
2025
Q4 		$362K Buy
14,243
+2,755
+24% +$61.4K ﹤0.01% 2705
2025
Q3 		$185K Buy
+11,488
New +$186K ﹤0.01% 2783

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Quantinno Capital Management's IMVT Position: Q1 2026 in Review

Quantinno Capital Management increased its Immunovant (IMVT) stake by 181% in Q1 2026, buying an estimated $668K and bringing the position to 40,030 shares worth $994K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

Quantinno Capital Management first reported a position in IMVT in Q3 2025 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Quantinno Capital Management held 40,030 shares of Immunovant worth $994K as of Q1 2026.
  • Quantinno Capital Management bought 25,787 Immunovant shares in Q1 2026, an estimated $668K.
  • Immunovant made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2169 holding.
  • Quantinno Capital Management first reported a position in Immunovant in Q3 2025 and has held it in 3 quarters since.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.